Beaten - healthylife7.com

Is Neurocrine Biosciences (NBIX) Fully Valued As It Enters Phase 1 Obesity Testing?

By healthylife7August 10, 20260

Neurocrine Biosciences (NBIX) has drawn fresh attention after announcing a Phase 1 first in human study of NBIP 1968, a triple agonist candidate aimed at obesity treatment and intended for once weekly subcutaneous dosing

What's Hot

Is Neurocrine Biosciences (NBIX) Fully Valued As It Enters Phase 1 Obesity Testing?

Yuthika Launches Premium Shower Gel Collection Inspired by Nature

The power of genetic testing: new screening methods are catching rare diseases before symptoms start

Browsing: Beaten

3 Beaten

Is Neurocrine Biosciences (NBIX) Fully Valued As It Enters Phase 1 Obesity Testing?

Yuthika Launches Premium Shower Gel Collection Inspired by Nature

The power of genetic testing: new screening methods are catching rare diseases before symptoms start

What horses can teach us about supporting those who answer the call

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Is Neurocrine Biosciences (NBIX) Fully Valued As It Enters Phase 1 Obesity Testing?

Yuthika Launches Premium Shower Gel Collection Inspired by Nature

The power of genetic testing: new screening methods are catching rare diseases before symptoms start

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: Beaten